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ABSTRACT A highly efficient method for the generation
of insertion mutations is described. The procedure involves the
use of a 220-base-pair (bp) Ec6RI fragment bearing the SuIIIl
suppressor tRNA gene as an insertional mutagen. The plasmid
DNA to be mutagenized is linearized by a variety of means,
and the suppressor fragment is ligated into the site of cleavage.
Successful insertion mutants can be readily detected in Esche-
richia coli carrying lac- amber mutations on MacConkey lac-
tose plates; virtually 100% of the red colonies contain inser-
tions of the fragment. Subsequent removal of the SulIl+ gene
and recyclization leaves a 12-bp insertion if the original cleav-
age was blunt-ended and a 9-bp insertion if the original cleav-
age generated 3-bp cohesive termini. This technique, as well as
conventional linker mutagenesis with decamer and dodecamer
linkers, was used to generate a large library of insertion muta-
tions in cloned DNA copies of the genome of Moloney murine
leukemia virus. A number of viable mutants were isolated
bearing 9-, 10-, and 12-bp insertions in various domains of the
genome. The map positions of the viable mutations suggest
that the viral long terminal repeats and portions of the gag and
env genes are quite insensitive to alteration. Although most of
the mutations were stable for many passages, some of the mu-
tants lost the inserted DNA; we presume that the insertion was
somewhat deleterious in these mutants and that continued pas-
sage of the virus selected for overgrowth by a revertant.
The in vitro mutagenesis of cloned genes has been one of the
most powerful tools in the elucidation of the relationship be-
tween structure and function of DNA sequences. By intro-
ducing defined alterations in a sequence and correlating the
changes with alterations in gene function, it has been possi-
ble to define such features as transcriptional promoters (1-
4), RNA splicing signals (5), RNA polyadenylylation signals
(6), ribosome binding sites (7), and protein domains needed
for particular enzymatic activities (8, 9). Our power to carry
out such analyses has been increased enormously as the
techniques used to make the defined alterations have be-
come increasingly sophisticated (10).
The use of these techniques is sometimes limited by our
ability to choose likely target regions for mutagenesis. When
there is no information defining which parts of a gene are
essential for a particular function, then narrowly targeted in
vitro mutagenesis is not helpful in the localization of that
function. In such cases, it is necessary to generate a large
library of mutants with defined alterations scattered
throughout the cloned DNA and to screen these mutants for
a desired phenotype. One of the best ways to construct such
a library is by "linker insertion" mutagenesis (11): a circular
target DNA is linearized with a nuclease, and a short syn-
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thetic oligonucleotide sequence containing a restriction en-
zyme recognition site is inserted at the position of cleavage
in the target DNA. The resulting mutations can be readily
mapped simply by determining the site of cleavage by the
restriction enzyme that recognizes the inserted sequence.
We have constructed several libraries of mutants of Mo-
loney murine leukemia virus (M-MuLV) by the insertion of
EcoRI linkers at random positions in a cloned DNA copy of
the viral genome. During the course of these studies, we
found that the efficiency of the process was highly variable;
linkers were added poorly to ends formed by some nucleases
and very few linker insertions could be successfully formed.
To circumvent this difficulty, we have developed an im-
proved method by which rare insertion events can be readily
detected, obviating the screening of large numbers of clones
by electrophoresis to identify insertions. By this method,
large libraries of mutants, free of wild-type parental DNA,
can be efficiently constructed. In this report, we describe
the method and its application to the genetic analysis of the
genome of M-MuLV. We have screened libraries of mutants
and, after transfection of NIH/3T3 cells, have recovered nu-
merous clones that are still replication competent. The posi-
tions of the mutations in these clones define noncoding and
coding regions of the viral genome that are dispensible for
replication or that can tolerate insertions without deleterious
effects on the virus.
MATERIALS AND METHODS
Bacteria. Escherichia coli strain HB101 (rec A13,- hsdRl,
hsdM-, lac Y1, supE44) was used as the recipient cell for
most DNA transformations (12). To detect the presence of
the SuIII+ suppressor gene, strain CC114 [del(ara,leu)7697,
lacZ- amYJ4, galU, galK, hsdR-, hsdM', strAr, rifr, argE-
am, srl::TnIO, recAl] was used as recipient. This strain, con-
structed and generously provided by C. Manoil, gave high
transformation efficiencies comparable to that of HB101.
Plasmid DNAs. Plasmids used in this work include p8.2
(13), a complete permuted copy of the M-MuLV genome in-
serted in the HindIII site of pBR322; pACYC177 (14), a vec-
tor containing no EcoRI sites; pMOV9 (15), containing an
integrated proviral copy of the M-MuLV genome; pBR328
(16), a vector with a single Pvu II site; and piVX (17), a plas-
mid carrying the SuIII+ gene.
Enzymatic Reactions. Synthetic oligomers (New England
Biolabs) were phosphorylated with T4 polynucleotide kinase
(Bethesda Research Laboratories) at a concentration of 1 ,ug
per 10 A.l in buffer (50 mM Tris HCl, pH 7.4/10 mM
MgCI2/10 mM dithiothreitol) containing 1 mM ATP (5 Ci/
mmol; 1 Ci = 37 GBq) for 1 hr at 370C. One-tenth of the
preparation (0.1 pug) was ligated to DNA (1-5 ,ug) in the same
Abbreviations: M-MuLV, Moloney murine leukemia virus; kb, kilo-
base(s); bp, base pair(s).
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buffer overnight at 15'C before purification by agarose gel
electrophoresis. Restriction enzymes were used according to
the specifications of the' manufacturer (New England Bio-
labs). Partial cleavages were carried out at 250C for various
times (1-60 min). Typically, 40 gg of DNA in 200 1.l of the
recommended buffer was digested with 1 unit of enzyme,
and aliquots were removed for analysis. Optimal times for
formation of full-length linear DNAs were usually 20-40
min. Cohesive ends ofDNA fragments were filled in with the
Klenow fragment (18) of DNA polymerase I (New England
Biolabs) in buffer (50 mM Tris HCl, pH 7.4/10 mM
MgCl2/10 mM dithiothreitol) containing the four deoxyri-
bonucleotides (1 mM each). Ends were blunted before addi-
tion of linkers by treatment with S1 nuclease (19) (Boeh-
ringer Mannheim) in buffer (300 mM NaCl/30 mM sodium
acetate, pH 4.6/4 mM ZnCl2) at 20'C for 20 min. Reactions
with terminal transferase (20, 21) obtained from Bethesda
Research Laboratories were carried out with -0.5 ,ug of
DNA in 100 ,ul of buffer (200 mM potassium cacodylate, pH
7.2/1. mM mercaptoethanol/1 mM CoC12/50 ,uM dGTP or
dCTP) for 1-4 min at 25°C. DNAs to be joined were mixed,
heated to 70°C for 5 min, and then cooled to 40°C for 4 hr
before transformation of bacteria.
DNA sequence analysis was as described (22).
Bacterial Transformations. Transformation of strain
CC114 was carried out according to standard protocols,
treating the cells with buffer (50 mM CaCl2/10 mM Tris HCl,
pH 7.4) to induce competence. Growth on MacConkey
plates was allowed for 24 hr for unambiguous identification
of colonies bearing the suppressor gene. We have noticed
that clones harboriig the SuIII+ gene in high copy number
have an increased generation time and, therefore, become
visible later as macroscopic colonies on the plates.
Animal Cell Transfections. Viral DNAs were introduced
into NIH/3T3 cells by the DEAE dextran method (23) or by
calcium phosphate coprecipitation (24, 25) with equivalent
results. Permuted viral inserts were excised by cleavage with
HindIlI and polymerized with T4 DNA ligase before trans-
fection; proviral clones were used without modification.
Analysis of Viral DNA. Preintegrative viral DNA was ex-
tracted from cells by the Hirt (26) procedure 24 hr after infec-
tion. The DNA was treated with a selected restriction en-
zyme, displayed by agarose gel electrophoresis, transferred
to nitrocellulose (27), and detected by hybridization with a
radioactive viral DNA probe.
Detection of Virus. Fully wild-type replication-competent
virus was detected by the XC plaque assay (28); transmissi-
bility was determined by reverse-transcriptase assay (29).
DNAs were linearized by treatment with restriction enzymes
Hae III or Alu I. These enzymes produce blunt ends and can
make cleavages at a large number of sites in the M-
MuLV genome: a total of 64 and 36 sites, respectively, are
present in the 8.8-kb provirus. After limited digestion, link-
ers were added with T4 DNA ligase, and the full-length lin-
ear molecules were isolated by agarose gel electrophoresis.
The mixture was digested with EcoRI, circles were reformed
by ligation, and clones were prepared from bacterial trans-
formants. With this technique, our best experiments pro-
duced populations in which -50% of the DNAs were found
to contain novel EcoRI sites. In some cases, however, only
10% contained an EcoRI site. Furthermore, independently
isolated inserts at a given site sometimes generated different
phenotypes, suggesting that sometimes insertions of differ-
ent lengths had occurred.
The positions of a large number of these insertion muta-
tions were determined by digestion with pairs of restriction
enzymes (EcoRI and HindIII, or EcoRI and Sal I) followed
by agarose gel electrophoresis. Once the approximate map
position was determined from these digests, the exact site of
insertion was mapped by measuring the distance from the
linker to a nearby restriction site on acrylamide gels. When
two Hae III or Alu I sites were close together, DNA se-
quence analysis was used to determine the insertion site.
Mutations were assigned numbers according to the base po-
sition of the insertion starting at the left edge of the left long
terminal repeat of a proviral copy of the M-MuLV genome.
One collection of such insertions is shown in Fig. 2. Inser-
tions are fairly uniformly distributed along the genome.
Suppressor-Linker Insertional Mutagenesis. To improve
these methods, a novel linker was constructed (Fig. 3). A
220-base-pair (bp) fragment containing the SuIII+ tyrosine
tRNA gene (SupF) was excised from the piVX plasmid (17)
and the 4-bp cohesive ends were filled in by treatment with
the Klenow fragment of DNA polymerase I. Synthetic oc-
tamer linkers containing the cleavage site for Pvu II were
added with T4 DNA ligase, restoring the complete EcoRI
sites at each end of the fragment (Fig. 3). Subsequent cleav-




AG POL ENV -G
RESULTS
Conventional Linker Insertion Mutagenesis. To construct a
library of mutants of M-MuLV, we chose to insert synthetic
oligonucleotides containing an EcoRI restriction site, be-
cause the M-MuLV genome contains no site for cleavage by
the EcoRI restriction enzyme, and because these linkers are
readily available. Two plasmids encoding the genorne of M-
MuLV were constructed containing no EcoRI sites in other
positions, including the vector. In one construct, the permut-
ed copy of the viral genome in plasmid p8.2 (9, 13) was ex-
cised from the vector and transferred into the HindIII site of
the vector pACYC177 (14) to form the plasmid termed
pA8.2. In the other construct, the proviral insert of pMOV9
(15) was excised from its vector and transferred by G'C tail-
ing (21) into the vector consisting of the 2.4-kilobase (kb)
Hae II fragment of pACYC177. The resulting plasmid,
termed pT11, was free of EcoRI sites and contained a mini-
mum (5 kb) of nonviral sequences.
In our initial experiments, conventional linker insertions
were made (Fig. 1). To mutagenize the clones, plasmid
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FIG. 1. Linker insertion mutagenesis. A circular plasmid con-
taining a DNA copy of the genome of M-MuLV is cleaved by limited
digestion with a selected restriction enzyme. The full-length linear
DNAs are purified and ligated to EcoRI linkers. Finally, the DNAs
are treated with EcoRl and recircularized by treatment with DNA
ligase at low DNA concentrations. The result is a library of mutant
DNAs each containing a single EcoRI linker insertion.
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FIG. 2. The position of insertion of EcoRI linkers in a library of
mutants of M-MuLV. Thirty-one insertion mutations into plasmid
pA8.2 were mapped by cleavage with HindI11 and EcoRI, and with
Sal I and EcoRI. The approximate positions of the new EcoRI sites
in the Moloney genome are indicated by the arrows.
taining the SuIII+ gene, flanked by EcoRI recognition se-
quences 3 bp from each end. This molecule was amplified by
cloning in the Pvu II site of the vector pBR328; large
amounts of this reagent could be readily prepared as needed
by excision of the fragment with Pvu II and by purification
on an acrylamide gel.
Libraries of mutants were generated by ligating this blunt-
ended fragment to a linearized target DNA and directly
transforming lac- am E. coli (strain CC114) with the ligation
mix. The cells were plated on MacConkey lactose plates
containing ampicillin, and red (Lac') colonies were picked
and pooled. One collection of such mutants was generated
with pT11 DNA cleaved with Sma I (Table 1); only 30% of
the colonies were red, but every red colony (60/60) con-
tained an insertion mutant (data not shown). DNA was pre-
pared from pooled red colonies, cleaved with EcoRI to re-
move the SuIIIO gene, recircularized, and introduced into
cells. Every white (Lac-) colony contained DNA with a sin-
gle simple insertion of the EcoRI site. Sequence analysis of
one clone showed that 12 bp had been inserted as expected
(data not shown). From this library, all five possible inser-
tions at Sma I sites were recovered (Table 1).
A second library of mutants was generated by an exten-
sion of the above procedure. Plasmid pT11 DNA was linear-
ized by partial digestion with Sau96I, which cleaves fre-
quently (87 times in M-MuLV) and which leaves 3-bp cohe-
sive ends. The linear molecules were blunted with S1
nuclease under mild conditions and ligated to the suppressor
linker. As before, every red (Lac+) colony contained an in-
sertion mutant; in this case, the ability to detect these mu-
tants by a plate assay was essential, because the fraction of
the total colonies containing inserts was often low (5%-
10%). After excision of the suppressor fragment from DNAs
of pooled red colonies, clones were formed that contained
the same 12-bp insertion as before, but with a loss of 3 bp to
yield a net insertion of 9 bp. Mapping the position of the
insertion in many of the clones showed a wide distribution of
insertion sites as had been found for synthetic linker inser-
tions. Those DNAs with inserts outside the proviral DNA
were not analyzed further.
Isolation of Viable Insertion Mutants of M-MuLV. Mem-
bers of the libraries generated as described above were test-
ed for their ability to induce XC syncytia after DNA trans-
fection of NIH/3T3 cells in culture (9). Viable mutants from
10-bp insertion libraries were detected, but at low frequen-
cies; all such mutants were clustered in noncoding regions
(Table 2). Thus, any frameshift mutations that mapped in the

























FIG. 3. Construction and use of the suppressor-linker (Sup-
Link) DNA fragment. The 220-bp fragment from plasmid piVX bear-
ing the E. coli SuIII+ gene was ecised by EcoRL cleavage, and oc-
tamer linkers containing the recognition sequence for Pvu II were
added. Cleavage with Pvu II yielded the "Sup-Link" DNA, a blunt-
ended DNA containing the Sulll+ gene flanked by EcoRI sites. Suc-
cessful insertion of this DNA into a target plasmid (wavy lines)
could be readily detected by the suppression of a lac amber gene
resident in the bacterial host chromosome. Excision of the insert
generates a 12-bp insertion (bottom line).
and 9-bp insertions were very common, appearing as 15%
and 33% of the total mutants, respectively (Table 1). The
insertions in these mutants were located at many positions in
the viral genome (Table 2). Many were found in the U3 re-
gion of the long terminal repeat sequences, containing tran-
scriptional promoter and enhancers. Other mutants were ob-
tained with insertions in the region upstream of the gag
gene, in gag proteins P12 and P10, in the 3' part of the pol
gene, and throughout the env gene. Thus, these regions are
at least moderately flexible without serious effects on the
replication of the virus. Conspicuously absent from the via-
ble mutants were any insertions in gag proteins P15 and P30
and in the 5' portion of the pol gene. These regions may be
very sensitive to alterations and may be very critical for the
growth of the virus (ref. 30; unpublished observations).
Several of the mutants in coding regions of the genome,
although XC positive, reproducibly yielded fewer plaques
per ,g of applied DNA than the wild type (Table 2). Thus,
these mutants may show quantitative defects in replication
functions.
Stability of the Insertion Mutations. Those mutant viruses
capable of inducing XC plaques were analyzed further to as-
sess the stability of the alteration. Virus was recovered from
the cell cultures after transfection and was used to infect
fresh NIH/3T3 cells at high multiplicity. The preintegrative
DNA intermediates were isolated (26) and analyzed by agar-
ose gel electrophoresis followed by blot hybridization with a
labeled virus-specific probe. The retention of the EcoRI site
Table 1. Libraries of insertion mutants
Library Parent plasmid Mutagen Target site Members, no. Viable/tested % viable
1 pA8.2 12-mer linker Alu I 12 1/5
2 pA8.2 10-mer linker Hae III 142 3/12
3 pT1l 12-mer linker Hae III 75 9/60 15
4 pT11 Sup-Link Sma 1 5 3/5
5 pT11 Sup-Link SauI 120 11/33 33
Sup-Link, suppressor-linker.
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Table 2. Properties of selected mutants
Nucleotide
Site of position of Region XC plaque Trans- EcoRI site
Mutant insertion insertion affected Mutagen formation* missibilityt maintainedt
in479-12 Sma I 479 R in 5' LTR Sup-Link + +
in845-12 Hae III 845 gPr80gag 12-mer + + +
inl525-12 Hae III 1525 P12 12-mer + + +
in1568-9 Sau96I 1568 P12 Sup-Link + + ND
inl688-12 Hae III 1688 P12 12-mer + + ND
in2504-12 Hae III 2504 P30/P10 12-mer +/- +
in2636-9 Sau96I 2636 P10 Sup-Link + + +
in2645-9 Sau96I 2645 P10 Sup-Link + + +
d15395-447 Sau96I 5395 Pol Sup-Link - +
in6199-12 Sma I 6199 Pol Sup-Link + + +
in6438-12 Hae III 6438 Env 12-mer + + +/-
in7030-9 Sau96I 7030 Env Sup-Link +/- + +/-
in7407-9 Sau96I 7407 Env Sup-Link + + +
in7442-9 Sau96I 7442 Env Sup-Link +/- + +/-
in7601-12 Hae III 7601 Env 12-mer +/- + ND
in8299-12 Alu I 8299 U3 in 3' LTR 12-mer + + +
in8397-10 Hae III 8397 U3 in 3' LTR 10-mer + + +
in8397-12 Hae III 8397 U3 in 3' LTR 12-mer + + +/-
in8442-10 Hae III 8442 U3 in 3' LTR 10-mer + + +
in8470-9 Sau96I 8470 U3 in 3' LTR Sup-Link + + ND
in8472-12 Hae III 8472 U3 in 3' LTR 12-mer + + +
in8517-10 Hae III 8517 U3 in 3' LTR 10-mer + + +
in8530-9 Sau96I 8530 U3 in 3' LTR Sup-Link + +
in8743-12 Sma I 8743 R in 3' LTR Sup-Link + +
inlO74-12 Hae III 1074 P15 12-mer - - ND
in6527-12 Sma I 6527 Env Sup-Link - - ND
in6684-12 Sma I 6684 Env Sup-Link - - ND
Those insertion mutants found to be replication competent are listed. Three defective viruses whose insertions were
mapped in detail are also shown. LTR, long terminal repeat; Sup-Link, suppressor-linker.
*+, Wild-type levels (-1000 XC plaques per 100 ng); +/-, low levels (1-10 per 100 ng); -, no plaques.
t+, Release of particles after viral infection as judged by reverse transcriptase assay (29).1+, Complete sensitivity to EcoRI after 2 weeks of passage; +/-, partial resistance (10%-50%) after 2 weeks; -, complete
loss of the site; ND, not done.
could be demonstrated by sensitivity of the DNA to EcoRI;
loss of the mutation was indicated by the appearance of
EcoRI-resistant DNA. The mutants that gave rise to a wild-
type number of XC plaques proved to be quite stable: the
DNAs were completely sensitive to EcoRI digestion and
gave rise to DNA fragments of the appropriate sizes predict-
ed by the location of the insertion (Fig. 4). After extended
passage in culture, some of these mutants did reveal the ap-
pearance of low levels of EcoRI-resistant DNA (Fig. 4).
Those mutants that consistently yielded few XC plaques
showed the most rapid loss of the site. Two mutants with
insertions in the R region of the long terminal repeat also
showed rapid loss of the mutations; these mutants (in479-12,
in8743-12) are exceptional because loss can occur by special
means during retroviral replication. Analysis of these mu-
tants will be described elsewhere (unpublished results).
DISCUSSION
The techniques of in vitro mutagenesis have manifold appli-
cations in the correlation of structure and function of genes.
We have described a procedure for the generation of 9- and
12-bp insertion mutations in which a short DNA fragment
carrying a selectable marker is used as the initial insertional
mutagen. The method is an improvement over previous
methods (11) for synthetic DNA linker insertions at blunt
restriction sites in that fewer steps are involved and 100% of
the resulting clones have acquired insertion mutations.
Thus, the creation of large libraries of independent insertion
mutants is an easy task. In the construction of insertions at
sites that are cut to leave cohesive ends, these advantages
become even more important. The efficiency of successful
ligation of dodecamers to nuclease Sl-blunted ends by the
usual procedures is often low (on the order of 10%), and
many colonies must be analyzed to recover a few mutants.
The use of the suppressor-linker fragment allows the rapid
detection of mutants by a simple plate test and obviates the
l 2 3 4 5 6
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FIG. 4. Southern blot of viral DNAs synthesized by mutants of
M-MuLV. Mutant viral DNAs were introduced into cells by trans-
fection, and virus was allowed to spread through the cultures for a
period of 2 weeks. Virus was then harvested and used to infect fresh
NIH/3T3 cells at high multiplicity. The unintegrated viral DNAs
were isolated, cleaved, and analyzed by gel electrophoresis and blot
hybridization. Lanes 1, 3, and 5, DNAs were cleaved with HindIll.
Circular molecules were cleaved once to yield 8.8- and 8.2-kb linear
molecules; linear molecules were also cleaved once to yield 5.3- and
3.5-kb fragments. Lanes 2, 4, and 6, DNAs were cleaved with Hin-dIll and EcoRI. New cleavages indicate the existence of an EcoRI
site. Lanes 1 and 2, wild-type virus. A plasmid DNA bearing an
EcoRI insertion outside the transcribed provirus was applied to
cells. Lanes 3 and 4, mutant in8397-12. Lanes 5 and 6, mutant
in8472-12.
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screening of large numbers of clones by more arduous proce-
dures. We have made the most extensive use of the proce-
dure to make 12-bp insertions after removal of 3-bp cohesive
ends, yielding a net 9-bp insertion. The same linker could
also be used to make 15-bp insertions by joining to cohesive
ends that are filled in with the Klenow fragment of DNA
polymerase I. In our hands, however, the efficiency of this
procedure was lower than that of joining to nuclease S1-
blunted ends.
After the suppressor-linker is inserted and the suppressor
gene is excised from a clone, an EcoRI site is generated at
the point of insertion. This makes it easy to map the muta-
tion and, in addition, can be used to detect the presence of
the mutation after reintroduction of the DNA into the natural
host. Further experiments (unpublished) have made use of
the sites as genetic markers in studies of recombination be-
tween homologous regions of two different virus genomes.
We were able to assess the stability of the mutations dur-
ing passage of the viruses by examining the persistence of
the recognition site. Most insertions were quite stable and
were retained over many generations. Occasionally, sites
were lost during passage; the structure present after the loss
is not yet known. Those sites lost from the central parts of
the genome may be lost by point mutation, by deletion, or
possibly by recombination with endogenous sequences; it is
likely that the virus may not be restored completely to the
wild type. It is interesting that the mutants that yielded fewer
XC plaques after transfection often lost the site. We propose
that these mutations are somewhat deleterious and that loss
of the site results in selective growth advantage. Two mu-
tants were exceptional (in479-12 and in8743-12); these DNAs
yielded normal numbers of plaques but quickly lost the
EcoRI site. Further studies have suggested that in these cas-
es loss occurs during reverse transcription.
The creation of a unique EcoRI site in a DNA clone can
serve as a point of entry for deletion mutagenesis in se-
quences otherwise devoid of infrequent cleavage sites and
bearing only highly reiterated restriction sites. One could use
the suppressor-linker to create deletions and simultaneously
establish unique sites at the position of the deletion if the
DNA is treated with an exonuclease before ligation to the
suppressor-linker.
The general technique of insertion mutagenesis has en-
abled us to define several domains of the M-MuLV genome
that are amenable to small alterations without deleterious ef-
fects on the virus. Using decamer linker inserts, we have
been able to generate viable mutations in a variety of non-
coding regions. No insertions that would result in frameshift
mutations of the gag, poi, or env genes were found to leave
the viral genome competent to replicate. Numerous viable
mutations in viral genes were created with 9- and 12-bp in-
sertions; these mutations define flexible regions of the viral
proteins encoded on the viral genome. This procedure could
be as readily applied to other cloned genes. During the
course of analyzing the mutations in coding regions, we
found that the frequency of appearance of viable mutants in
a population was dependent on the size of the insertions.
Specifically, 33% of the 9-bp insertions were viable, while
only 15% of the 12-bp insertions were viable. Thus, a net
insertion of three amino acids appears to be less disruptive to
the gene products of M-MuLV than four amino acid inser-
tions, at least in the limited number of cases tested. One ex-
planation is that the 9-bp insertions might, by virtue of the
difference in sequence, result in the insertion of less destabi-
lizing amino acids than the 12-bp insertions. Clearly, each
insertion can encode any of three different sets of amino ac-
ids depending on the translational reading frame through theinsertion; it is not obvious by inspection alone that the 12-bplinker insertions would necessarily encode unusually disrup-
tive amino acids relative to the amino acids inserted by the
suppressor linker. It seems likely that, in general (and in any
given gene), short insertions may generate a higher frequen-
cy of functionally active gene products.
No viable- insertions have yet been mapped to the gag
genes encoding P30 or P15, or to the region of the pol gene
encoding reverse transcriptase. This result suggests that the
products of these genes play critical roles in the life cycle of
M-MuLV and that the proteins have strict structural require-
ments. The conclusion is supported by other genetic data
(refs. 9 and 30; unpublished data).
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